Evidence map›Paper›PMID 34040942›Full record

ArticleGlobal heart2021

WHF Position Statement on COVID Vaccination.

F Thienemann, G Chakafana, D Piñeiro, F J Pinto, P Perel, K Singh, J-L Eiselé, D Prabhakaran, K Sliwa

Registry-linked trialAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Global heart, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04475471 (WHF COVID-19 and Cardiovascular Disease Survey), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04475471 unknown statusnot on this map

WHF COVID-19 and Cardiovascular Disease Survey

TypeobservationalSponsorPublic Health Foundation of IndiaRan2020 to 2023Enrolled5,200ConditionsCOVID-19, Cardiovascular Diseases
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advanced Materials for SARS-CoV-2 Vaccines.Advanced materials (Deerfield Beach, Fla.) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

F ThienemannGeneral Medicine and Global Health (GMGH), Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, ZA.
G ChakafanaCape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, ZA.
D PiñeiroUniversidad de Buenos Aires, AR.
F J PintoSanta Maria University Hospital, CAML, CCUL, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, CT.
P PerelDepartment of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, World Heart Federation, CH.
K SinghPublic Health Foundation of India, Gurugram, Haryana, IN.
J-L EiseléDepartment of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, World Heart Federation, CH.
D PrabhakaranCentre for Chronic Disease Control, New Delhi, Public Health Foundation India, Gurugram, Haryana, India World Heart Federation, London School of Hygiene & Tropical Medicine, GB.
K SliwaCape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, ZA.

Funding

Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in IndiaK43TW011164 · FIC · PUBLIC HEALTH FOUNDATION OF INDIA · PI SINGH, KAVITA · 2019 to 2023
$342k
FIC NIH HHS K43 TW011164
6 · The paper itself

Abstract

The current COVID-19 pandemic has challenged health systems and communities globally. As such, several countries have embarked on national COVID-19 vaccination programmes in order to curb spread of the disease. However, at present, there isn't yet enough dosages to enable vaccination of the general population. Different vaccine prioritization strategies are thus being implemented in different communities in order to permit for a systematic vaccination of individuals. Here, on behalf of the World Heart Federation, we emphasize the need for individuals with Cardiovascular disease to be prioritized in national vaccine prioritization programmes as these are high risk individuals.

Indexed as

COVID-19 VaccinesHealth PrioritiesCardiovascular DiseasesComorbidityConsensus Statements as TopicGlobal HealthHumansSocieties, MedicalCOVID-19 Vaccinescardiovascular diseaseCOVID vaccinationglobal health

Identifiers

PMID34040942
PMCPMC8086730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.